Addressing Racial Disparities in Stress and Coping for Indolent Blood Cancers
Educational programs and psychological support addressing cancer-related beliefs and promoting healthier coping strategies are crucial for improving outcomes.
Read More
Author: Rebecca Shover
AAO eBook 2024
A curated eBook featuring AAO 2024 retinal vascular disease-focused studies, findings, and expert opinions.
Read More
CHEST eBook
A curated eBook featuring CHEST 2024 RCC-focused studies, findings, and expert opinions.
Read More
COPD eBook 2024
A curated ebook on COPD featuring recent studies, findings, and opinions from thought leaders.
Read More
Tardive Dyskinesia eBook 2024
A curated ebook on tardive dyskinesia featuring recent studies, findings, and opinions from thought leaders.
Read More
MRD Assessment May Improve Early Intervention for Inflammatory BC Recurrence
Molecular residual disease was detected about six months before radiographic confirmation of recurrence in patients with inflammatory breast cancer.
Read More
A Curious Case of COPD
A 69-year old patient from Southeast Asia presents with a 10-year history of cough and progressive dyspnea. The patient denies tobacco use or exposure.
Read More
SABCS Session Explores Treatment Considerations in Metastatic ER+ Breast Cancer
Oncologist Marla Lipsyc-Sharf, MD, and colleagues will discuss treatment considerations in metastatic ER+ breast cancer at the 2024 SABCS meeting.
Read More
2024 SABCS Meeting: What’s New in Early & Metastatic Breast Cancer?
This roundup includes a selection of abstracts on early and metastatic breast cancer presented at the 2024 San Antonio Breast Cancer Symposium.
Read More
The Latest on Breast Cancer: Research Updates From SABCS
New research on breast cancer was presented at the San Antonio Breast Cancer Symposium 2024, including updates on HER2-enriched disease and lymphedema.
Read More
Will You Be Attending “Case Based Clinical Approach to ER Positive Metastatic Breast Cancer” at SABCS?
Will you be attending “Case Based Clinical Approach to ER Positive Metastatic Breast Cancer” on Wednesday, December 11?
Read More
Will You Be Attending “Mind the Gap — Breast Cancer in the Young” at SABCS?
Will you be attending “Mind the Gap — Breast Cancer in the Young” at SABCS?
Read More
Outcomes, Distinctions in Double-Resistant/Double-Exposed CLL
Treatment resistance and toxicity remain critical challenges in managing chronic lymphocytic leukemia (CLL), according to researchers at the ASH Annual Meeting.
Read More
Financial Toxicity, Adherence, and QOL in Patients With CLL on First-Line Oral Oncolytic Therapy
Oral oncolytic therapies have revolutionized the treatment of chronic lymphocytic leukemia (CLL), offering improved outcomes and convenience for patients.
Read More
Will You Be Attending “Addressing Current Questions and Controversies in the Management of CLL” At ASH?
Will you be attending the morning symposia, “Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia – What Clinicians Want to Know” at ASH?
Read More
ESMO eBook
A curated eBook featuring ESMO 2024 RCC-focused studies, findings, and expert opinions.
Read More
What Do You Know About COPD?
Do you remember the COPD research presented at CHEST 2024? Test your knowledge now and see how you rank!
Read More
The 2024 ASHP Midyear Clinical Meeting at a Glance
The 2024 ASHP Midyear Clinical Meeting will feature multiple medical specialties, including infectious disease, diabetes, oncology, pain management, and more.
Read More
Will You Be Attending This Session at ASHP?
Will you be attending “The Upside of Imposter Syndrome” on Thursday, December 12, at ASHP?
Read More
Insights From Long-Term Follow-Up of the GMMG-HD6 Trial in MM
Addition of elotuzumab to standard therapy in transplant-eligible patients with MM did not improve PFS or OS in the long-term follow-up of the GMMG-HD6 trial.
Read More